Related Experiment Videos

In vitro studies on the adjuvanticity of Brucella fractions

Infection and Immunity
|November 1, 1982
PubMed

Insights

Two Brucella fractions act as in vitro adjuvants, enhancing immune responses to sheep red blood cells. These fractions exhibit both general immune activation and specific adjuvant effects, with distinct dose and cellular requirements.

Area of Science:

  • Immunology
  • Microbiology

Background:

  • Brucella fractions are known to modulate immune responses.
  • Understanding adjuvant mechanisms is crucial for vaccine development.

Purpose of the Study:

  • To investigate the adjuvant properties of two Brucella fractions (PI and SF) in vitro.
  • To differentiate between the polyclonal activation and specific adjuvanticity of these fractions.

Main Methods:

  • Mishell and Dutton-type cultures using B6/DB F1 mouse spleen cells.
  • Assessment of direct anti-sheep erythrocyte plaque-forming cell (PFC) responses.
  • Analysis of dose-response and cellular requirements (T-cells, adherent cells).

Main Results:

  • Both PI and SF fractions significantly enhanced anti-sheep erythrocyte PFC.
  • Polyclonal activation required high adjuvant doses and was T-cell independent.
  • Specific adjuvanticity required lower doses and was T-cell and adherent-cell dependent.
  • Adjuvant activity could be transferred via stimulated adherent cells or their supernatants, indicating soluble factors.

Conclusions:

  • Brucella fractions PI and SF function as in vitro adjuvants.
  • Polyclonal activation and specific adjuvanticity are dissociable functions with distinct requirements.
  • Soluble factors released by adherent cells mediate the cooperative immune effects of these Brucella fractions.

Related Concept Videos